Andreas Hafner and Stefan Brꢀse
UPDATES
In conclusion, we have shown that the trifluorome- General Procedure for Ethoxycarbonyldifluorometh-
thylation of the triazene moiety is possible with ylation of the Triazene Moiety
a facile two-step, one-pot synthesis in mostly good
The procedure as well as the equivalents werethe same as in
yields. This transformation can also be used for per-
the general procedure for the trifluoromethylation reactions,
fluoroethylation as well as ethoxycarbonyldifluorome-
thylation.
except for the solvent (DMSO instead of NMP) and the
TMS-agent (TMS-CF2COOEt instead of TMS-CF3).
Experimental Section
Acknowledgements
General
We thank the Landesgraduiertenfçrderung Baden-Wꢀrttem-
berg for financial support. We also want to thank Steffen
Styra for taking care of the 19F NMR measurement.
NMR spectra were recorded on a Bruker AM 400, a Bruker
Avance 300 or a Bruker DRX 500 spectrometer as solutions.
Chemical shifts are expressed in parts per million (ppm, d)
downfield from tetramethylsilane (TMS) and are referenced
to residual solvent peaks. All coupling constants (J) are ab-
solute values and J values are expressed in Hertz (Hz). The
description of signals includes: s=singlet, d=doublet, t=
triplet, q=quartet and m=multiplet. The spectra were ana-
lyzed according to first order. The signal structure in
13C NMR was analyzed by DEPT and is described as fol-
lows: + =primary or tertiary C-atom (positive signal), À=
secondary C-atom (negative signal) and Cquart =quaternary
C-atom (no signal). MS (EI) (electron impact mass spec-
trometry) was performed by using a Finnigan MAT 90
(70 eV). In cases where no (EI) mass spectra could be mea-
sured due to the high volatility of the compound, the GC-
MS was used for characterization. IR (infrared spectrosco-
py) was recorded on a FT-IR Bruker alpha. Solvents, re-
agents and chemicals were purchased from Aldrich, ABCR
and Acros. All solvents, reagents and chemicals were used
as purchased unless stated otherwise.
References
[1] O. Tomashenko, V. V. Grushin, Chem. Rev. 2011, 111,
4475–4521.
[2] a) R. Filler, Y. Kobayashi, Y. L. Yagupolskii, Organo-
fluorine Compounds in Medicinal Chemistry and Bio-
logical Applications, Elsevier, Amsterdam, 1993; b) P.
Kirsch, Modern Fluoroorganic Chemistry, Wiley-VCH,
Weinheim, 2004.
[3] a) D. A. Nagib, D. W. C. MacMillan, Nature 2011, 480,
224–228; b) Y. Ye, S. A. Kꢂnzi, M. S. Sanford, Org.
Lett. 2012, 14, 4979–4981; c) Y. Ye, M. S. Sanford, J.
Am. Chem. Soc. 2012, 134, 9034–9037; d) Y. Ji, T.
Brueckl, R. D. Baxter, Y. Fujiwara, I. B. Seiple, S. Su,
D. G. Blackmond, P. S. Baran, Proc. Natl. Acad. Sci.
USA 2011, 108, 14411–14415; e) A. Hafner, S. Brꢀse,
Angew. Chem. 2012, 124, 3773–3775; Angew. Chem.
Int. Ed. 2012, 51, 3713–3715; f) T. Kino, Y. Nagase, Y.
Ohtsuka, K. Yamamoto, D. Uraguchi, K. Tokuhisa, T.
Yamakawa, J. Fluorine Chem. 2010, 131, 98–105; g) Y.
Li, A. Studer, Angew. Chem. 2012, 124, 8345–8348;
Angew. Chem. Int. Ed. 2012, 51, 8221–8224; h) Y. Yasu,
T. Koike, M. Akita, Angew. Chem. 2012, 124, 9705–
9709; Angew. Chem. Int. Ed. 2012, 51, 9567–9571;
i) review: A. Studer, Angew. Chem. 2012, 124, 9082–
9090; Angew. Chem. Int. Ed. 2012, 51, 8950–8958.
[4] a) O. A. Tomashenko, E. C. Escudero-Adan, M. M.
Belmonte, V. V. Grushin, Angew. Chem. 2011, 123,
7797–7801; Angew. Chem. Int. Ed. 2011, 50, 7655–7659;
b) P. Novak, A. Lishchynskyi, V. V. Grushin, Angew.
Chem. 2012, 124, 7887–7890; Angew. Chem. Int. Ed.
2012, 51, 7767–7770; c) H. Kondo, M. Oishi, K. Fujika-
wa, H. Amii, Adv. Synth. Catal. 2011, 353, 1247–1252;
d) A. Hafner, S. Brꢀse, Adv. Synth. Catal. 2011, 353,
3044–3048; e) H. Morimoto, T. Tsubogo, N. D. Litvinas,
J. F. Hartwig, Angew. Chem. 2011, 123, 3877–3882;
Angew. Chem. Int. Ed. 2011, 50, 3793–3798; f) T.
Knauber, F. Arikan, G.-V. Rçschenthaler, L. J. Gooßen,
Chem. Eur. J. 2011, 17, 2689–2697; g) X. Mu, S. Chen,
X. Zhen, G. Liu, Chem. Eur. J. 2011, 17, 6039–6042;
h) X. Mu, T. Wu, H.-Y. Wang, Y.-L. Guo, G. Liu, J.
Am. Chem. Soc. 2012, 134, 878–881; i) L. Chu, F.-L.
Qing, J. Am. Chem. Soc. 2012, 134, 1298–1304.
General Procedure for Trifluoromethylation of the
Triazene Moiety
A vial equipped with a pressure-resistant crimp top and
a stirring bar was charged with 0.40 mmol of the triazene.
The reaction vessel was closed and 0.15 mL methyl iodide
(340 mg, 2.40 mmol) was added via syringe under an argon
atmosphere. The suspension was stirred at 1108C. After 5–
16 h the suspension was cooled to room temperature and re-
maining methyl iodide was removed under reduced pres-
sure. Now, 113 mg (0.60 mmol) copper iodide and 35 mg
(0.60 mmol) potassium fluoride were added. Then, 1.50 mL
dry NMP and 0.07 mL (68 mg, 0.48 mmol) TMS-CF3 were
added under argon and the suspension was heated to 608C
for another 16 h. The solution was diluted with diethyl ether
and washed with NH3 solution and 2M HCl. The organic
layer was dried over MgSO4. Finally, the solvent was re-
moved under vacuum and the crude product purified by
flash column chromatography.
General Procedure for Perfluoroethylation of the
Triazene Moiety
The procedure as well as the equivalents were the same as
in the general procedure for the trifluoromethylation reac-
tions, except for the solvent (DMF instead of NMP) and the
TMS-agent (TMS-C2F5 instead of TMS-CF3).
[5] a) X.-G-. Zhang, H.-X. Dai, M. Wasa, J.-Q. Yu, J. Am.
Chem. Soc. 2012, 134, 11948–11951; b) T. Liu, X. Shao,
4
ꢁ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 0000, 000, 0 – 0
ÝÝ
These are not the final page numbers!